ArticleScientific reports2025
A pattern and lock strategy integrating acoustic patterning and hydrogel crosslinking for stable cell architectures.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Cell patterning technology faces critical limitations in dynamic control, biocompatibility, and structural stability for reconstructing native tissues. Here, we establish an acoustic-hydrogel integration strategy that overcomes these challenges through synergistic physical-biological programming. Experimental validation using particle/red blood cells-patterned hydrogels demonstrated exceptional structural stability under physiological conditions. Fiber-optic spectroscopic sensing technology enabled long-term monitoring of the ex vivo deoxygenation process in patterned red blood cells. The "pattern-and-lock" paradigm fundamentally resolves the stability-biocompatibility trade-off by decoupling acoustic manipulation from hydrogel curing. Its translational significance spans precision transfusion platforms for red blood cells functionality screening and label-free microtissue models capturing dynamic metabolic processes. By converging acoustic programmability with hydrogel biofunctionality, this work provides a scalable biomanufacturing platform validated for next-generation tissue models and clinical diagnostics.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.